134 related articles for article (PubMed ID: 36457141)
1. Diagnostic utility of total NT-proBNP testing by immunoassay based on antibodies targeting glycosylation-free regions of NT-proBNP.
Li L; Semenov AG; Feygina EE; Yang C; Wang N; Chen C; Hu X; Ni X; Zhang Z
Clin Chem Lab Med; 2023 Feb; 61(3):485-493. PubMed ID: 36457141
[TBL] [Abstract][Full Text] [Related]
2. N-terminal-pro-B-type natriuretic peptide (NT-proBNP): reference range for Chinese apparently healthy people and clinical performance in Chinese elderly patients with heart failure.
Shi X; Xu G; Xia T; Song Y; Lin Q
Clin Chim Acta; 2005 Oct; 360(1-2):122-7. PubMed ID: 16002063
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
[No Abstract] [Full Text] [Related]
4. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
[TBL] [Abstract][Full Text] [Related]
5. Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus Cardiac Examination 2 Study.
Røsjø H; Dahl MB; Jørgensen M; Røysland R; Brynildsen J; Cataliotti A; Christensen G; Høiseth AD; Hagve TA; Omland T
Clin Chem; 2015 Aug; 61(8):1087-97. PubMed ID: 26056354
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.
Halfinger B; Hammerer-Lercher A; Amplatz B; Sarg B; Kremser L; Lindner HH
Clin Chem; 2017 Jan; 63(1):359-368. PubMed ID: 28062629
[TBL] [Abstract][Full Text] [Related]
7. Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.
Foo JY; Wan Y; Schulz BL; Kostner K; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
Clin Chem; 2013 Oct; 59(10):1523-31. PubMed ID: 23820130
[TBL] [Abstract][Full Text] [Related]
8. ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure.
Lewis LK; Raudsepp SD; Prickett TCR; Yandle TG; Doughty RN; Frampton CM; Pemberton CJ; Richards AM
Clin Chem; 2019 Sep; 65(9):1115-1124. PubMed ID: 31092393
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Analytical Performances and Comparison of 3 NT-proBNP Assays for Diagnosing Heart Failure.
Cho J; Lee JH; Lee SG
Arch Pathol Lab Med; 2023 Aug; 147(8):949-956. PubMed ID: 36308710
[TBL] [Abstract][Full Text] [Related]
11. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
[TBL] [Abstract][Full Text] [Related]
12. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
[TBL] [Abstract][Full Text] [Related]
13. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
14. Age affects the diagnostic accuracy of serum N-terminal pro-B-type natriuretic peptide for heart failure in patients with pleural effusion.
Zhang M; Jiang MP; Yan L; Wen JX; Zheng WQ; Hu ZD
Clin Biochem; 2023 Apr; 114():52-58. PubMed ID: 36669639
[TBL] [Abstract][Full Text] [Related]
15. Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Chen AA; Tung R; Anwaruddin S; Baggish AL; Januzzi JL
J Card Fail; 2006 Aug; 12(6):452-7. PubMed ID: 16911912
[TBL] [Abstract][Full Text] [Related]
16. Determining the optimal cutoff values of plasma N-terminal pro-B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years.
Lin CW; Zeng XL; Zhang JF; Meng XH
J Card Fail; 2014 Mar; 20(3):168-73. PubMed ID: 24361777
[TBL] [Abstract][Full Text] [Related]
17. Cutting Edge of Brain Natriuretic Peptide (BNP) Research - The Diversity of BNP Immunoreactivity and Its Clinical Relevance.
Kuwahara K; Nakagawa Y; Nishikimi T
Circ J; 2018 Sep; 82(10):2455-2461. PubMed ID: 30135320
[TBL] [Abstract][Full Text] [Related]
18. Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.
Semenov AG; Feygina EE
Adv Clin Chem; 2018; 85():1-30. PubMed ID: 29655458
[TBL] [Abstract][Full Text] [Related]
19. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.
Mueller T; Gegenhuber A; Poelz W; Haltmayer M
Clin Chim Acta; 2004 Mar; 341(1-2):41-8. PubMed ID: 14967157
[TBL] [Abstract][Full Text] [Related]
20. NT-proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials.
Werhahn SM; Becker C; Mende M; Haarmann H; Nolte K; Laufs U; Zeynalova S; Löffler M; Dagres N; Husser D; Dörr M; Gross S; Felix SB; Petersmann A; Herrmann-Lingen C; Binder L; Scherer M; Hasenfuß G; Pieske B; Edelmann F; Wachter R
ESC Heart Fail; 2022 Feb; 9(1):100-109. PubMed ID: 34850596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
